These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3689364)

  • 21. Does lipophosphoglycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins?
    Mendonça SC; De-Luca PM; Olafson RW; Jardim A; Coutinho SG
    Braz J Med Biol Res; 1994 Feb; 27(2):553-7. PubMed ID: 8081281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan.
    Desjardins M; Descoteaux A
    J Exp Med; 1997 Jun; 185(12):2061-8. PubMed ID: 9182677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein initiates transformation of Leishmania donovani and L. mexicana through binding to lipophosphoglycan.
    Mbuchi M; Bates PA; Ilg T; Coe JE; Raynes JG
    Mol Biochem Parasitol; 2006 Apr; 146(2):259-64. PubMed ID: 16417933
    [No Abstract]   [Full Text] [Related]  

  • 24. The interaction of aluminium with soluble protein kinase C from mouse brain.
    Katsuyama H; Saijoh K; Inoue Y; Sumino K
    Arch Toxicol; 1989; 63(6):474-8. PubMed ID: 2619561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced expression of lipophosphoglycan (LPG) and kinetoplastid membrane protein (KMP)-11 in Leishmania donovani promastigotes in axenic culture.
    Mukhopadhyay S; Sen P; Majumder HK; Roy S
    J Parasitol; 1998 Jun; 84(3):644-7. PubMed ID: 9645879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response.
    Srivastav S; Kar S; Chande AG; Mukhopadhyaya R; Das PK
    J Immunol; 2012 Jul; 189(2):924-34. PubMed ID: 22685311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial purification and characterization of a soluble protein kinase from Leishmania donovani promastigotes.
    Banerjee C; Sarkar D
    J Gen Microbiol; 1990 Jun; 136(6):1051-7. PubMed ID: 2384743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parasite glycoconjugates. Part 16: Synthesis of a disaccharide and phosphorylated di- and tri-saccharides from Leishmania lipophosphoglycan.
    Ross AJ; Sizova OV; Nikolaev AV
    Carbohydr Res; 2006 Aug; 341(11):1954-64. PubMed ID: 16697981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the mechanism of action of a bilayer stabilizing inhibitor of protein kinase C: cholesterylphosphoryldimethylethanolamine.
    Epand RM; Stafford AR; Bottega R; Ball EH
    Biosci Rep; 1989 Jun; 9(3):315-28. PubMed ID: 2775861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive inhibition by diacylglycerol of specific phorbol ester binding.
    Sharkey NA; Leach KL; Blumberg PM
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):607-10. PubMed ID: 6320198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pentosan polysulphate, standard heparin and related compounds on protein kinase C activity.
    Herbert JM; Maffrand JP
    Biochim Biophys Acta; 1991 Feb; 1091(3):432-41. PubMed ID: 1705825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
    Ward NE; O'Brian CA
    Mol Pharmacol; 1992 Feb; 41(2):387-92. PubMed ID: 1538715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lipophosphoglycan of Leishmania and macrophage protein kinase C.
    Descoteaux A; Turco SJ
    Parasitol Today; 1993 Dec; 9(12):468-71. PubMed ID: 15463696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Mononuclear Cell Procoagulant Activity by Lipophosphoglycan of Leishmania donovani.
    Del Prete R; Buongiorno MR; Mosca A; Miragliotta G
    Clin Microbiol Infect; 1995 Sep; 1(1):31-34. PubMed ID: 11866718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of protein kinase C by stilbenoids].
    Xu G; Zhang LP; Chen LF; Hu CQ
    Yao Xue Xue Bao; 1994; 29(11):818-22. PubMed ID: 7863783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leishmania donovani: inhibition of phagosomal maturation is rescued by nitric oxide in macrophages.
    Winberg ME; Rasmusson B; Sundqvist T
    Exp Parasitol; 2007 Oct; 117(2):165-70. PubMed ID: 17511987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leishmania donovani lipophosphoglycan inhibits phagosomal maturation via action on membrane rafts.
    Winberg ME; Holm A; Särndahl E; Vinet AF; Descoteaux A; Magnusson KE; Rasmusson B; Lerm M
    Microbes Infect; 2009 Feb; 11(2):215-22. PubMed ID: 19070677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements.
    Bernier R; Barbeau B; Tremblay MJ; Olivier M
    J Immunol; 1998 Mar; 160(6):2881-8. PubMed ID: 9510191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmania donovani Aurora kinase: A promising therapeutic target against visceral leishmaniasis.
    Chhajer R; Bhattacharyya A; Didwania N; Shadab M; Das N; Palit P; Vaidya T; Ali N
    Biochim Biophys Acta; 2016 Sep; 1860(9):1973-88. PubMed ID: 27288586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of the human phagocyte oxidative responses caused by Leishmania lipophosphoglycan (LPG): in vitro studies.
    Brandonisio O; Panaro MA; Marzio R; Marangi A; Faliero SM; Jirillo E
    FEMS Immunol Med Microbiol; 1994 Jan; 8(1):57-62. PubMed ID: 8156051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.